TipRanks
Go Ultimate55% OFF

Rici Healthcare Holdings Ltd. (1526) AI Stock Analysis

HK:1526

Rici Healthcare Holdings Ltd.

(HKEX:1526)

Select Model
Rating:73Outperform
Price Target:HKD 0.90â–¼(-2.92% Downside)
Action:reiterated
Date:08/21/26

Solid financial performance with strong cash flows and an attractive low P/E valuation are the primary drivers, while mixed technical signals provide only moderate support.

Positive Factors
Strong ProfitabilityHealthy gross, operating, and net margins indicate that the company converts revenue into profit effectively. This profitability provides internal funding for operations and investment, supports resilience across the care-facilities cycle, and can strengthen competitive positioning over the next several quarters.
Negative Factors
Meaningful LeverageAlthough leverage has improved, the sizable debt load still reduces balance-sheet flexibility. If operating conditions soften, debt service and refinancing needs could compete with investment or shareholder returns, making the company more sensitive to sustained pressure on earnings and cash flow.

Rici Healthcare Holdings Ltd. (1526) vs. iShares MSCI Hong Kong ETF (EWH)

-50%-40%-30%-20%-10%0%10%20%30%HK:1526-6.28%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 1.47B
Dividend Yield
2.16%
Average Volume (3M)
123.11K
Price to Earnings (P/E)
4.2
Beta (1Y)
0.10
Revenue Growth
1.25%
EPS Growth
12.60%
Country
Hong Kong
Employees
8,542
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Rici Healthcare Holdings Ltd. Business Overview & Revenue Model

Company Description

Rici Healthcare Holdings Limited operates as an investment holding company, managing a variety of healthcare establishments across the People's Republic of China. Its operations encompass general and specialized hospitals, clinics, and medical examin...

How the Company Makes Money

null

Rici Healthcare Holdings Ltd. Financial Statement Overview

Summary

Strong cash flow generation and solid income statement growth are offset by elevated though improving debt levels on the balance sheet.

Income Statement

75Positive

Balance Sheet

55Neutral

Cash Flow

80Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.79B2.80B2.92B2.99B2.38B2.38B
Gross Profit1.20B1.21B1.17B1.25B927.20M975.22M
EBITDA1.03B1.10B1.05B1.07B814.35M905.21M
Net Income296.78M307.13M297.32M363.80M290.79M181.55M
Balance Sheet
Total Assets4.69B4.88B4.86B4.64B4.57B4.54B
Cash, Cash Equivalents and Short-Term Investments1.10B1.18B1.12B811.21M720.14M784.36M
Total Debt1.90B2.01B2.30B2.27B2.30B2.74B
Total Liabilities2.99B3.16B3.48B3.52B3.66B3.95B
Stockholders Equity1.68B1.65B1.35B1.13B953.92M677.50M
Cash Flow
Free Cash Flow541.76M561.55M584.35M487.07M396.33M356.41M
Operating Cash Flow707.45M719.39M790.58M826.29M706.37M681.07M
Investing Cash Flow-199.93M-301.48M-140.02M-147.00M-273.99M-269.13M
Financing Cash Flow-454.75M-388.92M-351.23M-592.72M-495.23M-193.99M

Rici Healthcare Holdings Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price0.93

Price Trends

50DMA0.86Positive
100DMA0.93Negative
200DMA0.89Positive

Market Momentum

MACD0.01Negative
RSI57.05Neutral
STOCH97.33Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1526, the sentiment is Positive. The current price of 0.93 is above the 20-day moving average (MA) of 0.90, above the 50-day MA of 0.86, and above the 200-day MA of 0.89, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 57.05 is Neutral, neither overbought nor oversold. The STOCH value of 97.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1526.

Rici Healthcare Holdings Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

HK:1526 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:2219HK:221973OutperformHKD 1.66B8.346.97%10.27%3.85%-1.23%
HK:1526HK:152673OutperformHKD 1.47B4.1617.86%2.16%1.25%12.60%
HK:3309HK:330966NeutralHKD 1.05B10.105.57%2.35%4.75%―
HK:1846HK:184663NeutralHKD 703.50M285.710.20%2.00%20.54%-96.74%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HK:9906HK:990651NeutralHKD 936.00M23.355.59%―――
HK:3886HK:388641NeutralHKD 1.10B78.090.48%1.10%-3.26%―

* Healthcare Sector Average

Performance Comparison

-40%-20%0%20%HK:1526HK:9906HK:1846HK:2219HK:3309HK:3886Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:1526 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:1526Rici Healthcare Holdings Ltd.0.93-0.07-7.22%
HK:9906Honliv Healthcare Management Group Co Ltd1.56-0.05-3.11%
HK:1846EuroEyes International Eye Clinic Limited2.20-1.09-33.17%
HK:2219Chaoju Eye Care Holdings Ltd.2.360.010.43%
HK:3309C-MER Eye Care Holdings Limited0.85-0.91-51.81%
HK:3886Town Health International Medical Group Ltd.0.16-0.11-40.07%

Rici Healthcare Holdings Ltd. Corporate Events

Rici Healthcare Moves to Replace Auditor BDO With Rongcheng After Fee Review

Aug 28, 2026

Rici Healthcare Holdings Ltd. has announced a proposed change of auditor, with BDO resigning as the company’s auditor following the passing of a relevant resolution at an extraordinary general meeting. Subject to shareholder approval, the board...

Rici Healthcare Posts Softer Interim Results and Halts Interim Dividend

Aug 28, 2026

Rici Healthcare Holdings Ltd., a Cayman Islands–incorporated healthcare group listed in Hong Kong, operates through subsidiaries to deliver medical and healthcare services across mainland China, positioning itself within the growing Chinese hea...

Rici Healthcare Sets Board Meeting to Review Interim Results and Dividend

Aug 13, 2026

Rici Healthcare Holdings Ltd. has scheduled a board meeting for August 28, 2026, to review and approve the interim results for the six months ended June 30, 2026. The board will also consider the potential declaration of an interim dividend, a decisi...

Rici Healthcare Moves to Replace Auditor to Cut Costs

Jul 27, 2026

Rici Healthcare Holdings Ltd. has proposed changing its auditor, seeking shareholder approval to appoint Rongcheng Hong Kong CPA Limited after the resignation of BDO Limited. The move follows a failure to reach consensus on the audit fee for the 2026...

Rici Healthcare Clarifies Full Board Attendance at 2026 AGM

Jun 18, 2026

Rici Healthcare Holdings has issued a supplemental announcement regarding its annual general meeting held on June 17, 2026, clarifying that all directors attended either in person or via electronic means. The company emphasized that, aside from this...

Rici Healthcare Shareholders Approve All AGM Resolutions, Back Board Mandates

Jun 17, 2026

Rici Healthcare Holdings Ltd., a Hong Kong-listed Chinese healthcare services provider, reported that all resolutions at its 17 June 2026 annual general meeting in Shanghai were approved by shareholders via poll voting. The meeting covered adoption o...

Rici Healthcare Launches HK$100 Million Share Buyback to Signal Confidence and Support Valuation

Jun 17, 2026

Rici Healthcare Holdings has received shareholder approval to repurchase up to 10% of its issued shares and the board has authorised a buyback of up to HK$100 million using its own funds. The repurchased shares will be held as treasury stock, with fl...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 21, 2026